This site is intended for Healthcare Professionals only.

Medipharmacy secures £8.3m funding boost from Santander bank


Share post:

Medipharmacy Group has secured an £8.3m funding from Santander UK to support the acquisition of a purpose-built warehouse.

The company said the warehouse acquisition is fundamental to its plans to expand wholesale operations. It has also moved its day-to-day banking to Santander UK.

Medipharmacy, an independent community pharmacy chain operating in London, Kent, Surrey, and West Sussex, has 22 pharmacies, which deliver a full range of NHS and private services, including: prescription dispensing and deliveries; medicine reviews; smoking cessation; blood pressure testing; and many more which are provided through its on-site consulting rooms. 

Through its new banking relationship with Santander UK, Medipharmacy now has significant funding to support its growth aspirations. The funding enables the business to expand its wholesale operations for retail products sold in its pharmacies and to acquire a new warehouse and head office building, in East Grinstead, West Sussex. 

The new building is also being used to store medication and provides Medipharmacy with the additional capacity needed to expand its operations in future.

Sandeep Khosla, director of Medipharmacy, said: “Working with a bank that understands our business, expansion plans, values and goals was key. Santander UK’s funding package has enabled us to focus on our operations, especially during the pandemic, as pharmacies have been at the forefront of healthcare. By remaining open throughout, patients have had continuous supplies of medication and access to health advice and services. We’re very excited to now be able to expand the wholesale side of our business.”

Andy Casey, relationship director at Santander UK, said: “We’re delighted to be working with Medipharmacy Group, a well-known and respected company in the sector. By bringing together our expertise in the healthcare and pharmacy sectors, this package will support the management team’s ambitions for growth.”



Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

RPS makes Maudsley Deprescribing Guidelines available for RPS members

The Royal Pharmaceutical Society (RPS) has alerted free access to pharmacy members about a new addition to their...

Community pharmacists lead Pharmacy First digital launch

New pharmacy first platform, My Local Surgery, to connects patients with clinical services provided by community pharmacists  Community pharmacists...

CCA members celebrate hitting 200,000 Pharmacy First consultations milestone

Along with the pharmacy first celebrations, the Company Chemists Association has also highlighted the urgent need for GP...

General Election 2024: Political parties’ manifestos for community pharmacy

Political parties vow to expand the role of community pharmacy, alleviate financial strain, and establish a more sustainable...